AXIS Participaciones Empresariales

AXIS Participaciones Empresariales, Sociedad Gestora de Entidades de Capital Riesgo S.A., was established in 1986 to enhance venture capital activity in Spain, driven by the initiative of State-owned banking officials. Based in Madrid, it operates as the corporate venture capital arm of the Instituto de Crédito Oficial, which has wholly owned the firm since 1993. AXIS focuses on investing in companies across various stages, including seed, early, later, and growth phases, specifically targeting businesses in sectors such as B2B, commercial products, commercial services, healthcare, retail, infrastructure, and energy, all within Spain.

Guillermo Jiménez Gallego

Managing Director

Noelia López

Investment Manager

Rosario Nistal

Investment Manager

15 past transactions

Cabify

Venture Round in 2023
Cabify is a ride-sharing company founded in 2011 and headquartered in Madrid, Spain. It connects private users and businesses with transportation options that meet their needs, focusing on enhancing the overall travel experience for both passengers and drivers. The company offers on-demand services that include clean, modern vehicles equipped with amenities such as music, magazines, and water, all driven by specially trained drivers. Cabify emphasizes affordability, safety, and reliability in its rides, aiming to improve mobility in urban areas and contribute positively to the communities it serves. By prioritizing customer satisfaction and accessibility, Cabify seeks to redefine transportation in cities.

DeepUll

Series B in 2022
DeepUll is a biotechnology company dedicated to developing an innovative diagnostic system for early-stage sepsis. The company's approach focuses on rapidly identifying pathogens and delivering antibiogram results within hours. By utilizing artificial intelligence, DeepUll is able to determine the infective agent and provide insights into antimicrobial susceptibility, which helps reduce unnecessary antibiotic use. This system not only enables quick detection of pathogens and antibiotic resistance without the need for prior cultivation but also allows healthcare providers to assess a patient's immunological and functional status. Consequently, DeepUll's technology empowers doctors to predict the onset and progression of sepsis, facilitating timely clinical interventions even before symptoms manifest.

Adara Ventures

Grant in 2019
Adara Ventures is a venture capital investment firm based in Madrid, Spain, founded in 2005. The firm focuses on early-stage investments in deep-technology companies across Europe, particularly in sectors such as cybersecurity, data applications and infrastructure, DevOps, hardware components, digital health, and the energy transition. With 18 years of experience, Adara Ventures has invested in 43 companies and manages a portfolio worth €200 million. The firm partners with ambitious founders who possess the vision and capability to execute their ideas, emphasizing a strong commitment to innovation and growth in the technology landscape.

JME Venture Capital

Grant in 2019
JME Venture Capital is a venture capital firm established in 2009 and located in Madrid, Spain. The company focuses on investing in early-stage technology companies primarily within Spain. JME Venture Capital aims to support innovative startups by providing financial backing and strategic guidance, positioning itself as a key player in the Spanish venture capital landscape.

Samaipata

Grant in 2019
Samaipata is a venture capital investment firm established in 2016 and headquartered in Madrid, Spain, with additional offices in London and Paris. The firm specializes in early-stage investments, focusing primarily on seed and startup companies within the technology, e-commerce, and marketplace sectors across Europe, particularly in Spain. Samaipata seeks to support mission-driven entrepreneurs by investing between €0.5 million and €1.5 million in businesses that demonstrate potential for growth and network effects. The firm aims to build a portfolio of 20 to 25 companies, backing those that aspire to become leading players in their respective markets. Founded by experienced entrepreneurs, Samaipata is committed to nurturing innovative digital platforms in the European landscape.

SATLANTIS

Series A in 2016
SATLANTIS designs and manufactures high performance Earth observation payloads for small satellites. SATLANTIS is a company based in Spain and Florida (USA) that aims to connect the three vertices of the “triangle of knowledge” –universities, industries, and government agencies– to work together towards a common goal: to become a global leader in the use of constellation of microsatellites for scientific and commercial applications. SATLANTIS' premier product is iSIM, an “Integrated Standard Imager for Earth Observation Microsatellites”. An optical imaging product family for micro satellites (20-75 kg) that will provide an unparalleled performance and and flexibility for a fraction of the cost of today's Earth Observation instruments. The company is also closing alliances with partners in the US and Europe to develop the infrastructure for manufacture, integration, launch, and operations of standardized microsatellites.

Avanza Externalización de Servicios

Venture Round in 2012
Avanza Externalización de Servicios is a Spanish multinational specializing in outsourcing of services and processes.

OncoVision

Venture Round in 2012
Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia. They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology. They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment. ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases. Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide. Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience. With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.

Industrias H. Pardo

Venture Round in 2012
Industrias H. Pardo manufactures and markets hospital and nursing, geriatric, and home beds and furniture. The company offers armchairs, bedside tables, cranes, cribs, accessories, mattresses, covers, and pillows. It serves customers in Spain and internationally.

ERA Biotech

Venture Round in 2008
ERA Biotech specializes in the development and implementation of advanced cell-based biomanufacturing technologies. The company utilizes its proprietary tools, Zera and StorPro, to enhance performance in standard eukaryotic culture systems, which are widely used for the production of protein drugs, enzymes, and other biological products. Additionally, ERA Biotech focuses on biotechnology research, leveraging its technologies to create innovative solutions for existing enzymes and novel recombinant and plasmid DNA vaccines. The firm aims to deliver significant advancements in protein-cleavage and purification systems, positioning itself as a key player in the biotechnology sector.

Bionostra

Series B in 2005
It is one of the largest companies in the Spanish biotechnology sector. Its activity focuses on research, development and commercialization of biotechnology services. Born in 2000 under the initiative of a group of researchers of the Higher Council for Scientific Research (CSIC) and business professionals and is one of four companies in the business group Bionostra.

Philips Indal

Private Equity Round in 2003
Philips Indal is a manufacturer of lighting systems that specializes in the design, production, and installation of LED lighting products. The company offers a diverse range of outdoor lighting solutions in markets such as Brazil, France, Hong Kong, South Africa, and Australia, while providing indoor lighting products in Portugal and the Middle East. Additionally, Philips Indal develops horticultural lighting solutions for customers in Russia and Canada. With operations in over 50 countries, the company is committed to delivering innovative lighting systems, including smart technologies and energy-efficient options, to meet the varying needs of its global clientele.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.